411 related articles for article (PubMed ID: 17090575)
1. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease.
Swallow EB; Reyes D; Hopkinson NS; Man WD; Porcher R; Cetti EJ; Moore AJ; Moxham J; Polkey MI
Thorax; 2007 Feb; 62(2):115-20. PubMed ID: 17090575
[TBL] [Abstract][Full Text] [Related]
2. [Investigation of the quadriceps strength in patients with chronic obstructive pulmonary disease].
Ju CR; Chen RC
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Aug; 31(8):566-70. PubMed ID: 19080397
[TBL] [Abstract][Full Text] [Related]
3. Quadriceps and ankle dorsiflexor strength in chronic obstructive pulmonary disease.
Seymour JM; Ward K; Raffique A; Steier JS; Sidhu PS; Polkey MI; Moxham J; Rafferty GF
Muscle Nerve; 2012 Oct; 46(4):548-54. PubMed ID: 22987696
[TBL] [Abstract][Full Text] [Related]
4. Determining the minimally important difference in quadriceps strength in individuals with COPD using a fixed dynamometer.
Vaidya T; Beaumont M; de Bisschop C; Bazerque L; Le Blanc C; Vincent A; Ouksel H; Chambellan A
Int J Chron Obstruct Pulmon Dis; 2018; 13():2685-2693. PubMed ID: 30214186
[TBL] [Abstract][Full Text] [Related]
5. Inspiratory capacity predicts mortality in patients with chronic obstructive pulmonary disease.
Tantucci C; Donati P; Nicosia F; Bertella E; Redolfi S; De Vecchi M; Corda L; Grassi V; Zulli R
Respir Med; 2008 Apr; 102(4):613-9. PubMed ID: 18083020
[TBL] [Abstract][Full Text] [Related]
6. Quadriceps strength assessed by magnetic stimulation of femoral nerve in patients with chronic obstructive pulmonary disease.
Ju CR; Chen RC
Chin Med J (Engl); 2011 Aug; 124(15):2309-15. PubMed ID: 21933561
[TBL] [Abstract][Full Text] [Related]
7. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.
Soler-Cataluña JJ; Martínez-García MA; Román Sánchez P; Salcedo E; Navarro M; Ochando R
Thorax; 2005 Nov; 60(11):925-31. PubMed ID: 16055622
[TBL] [Abstract][Full Text] [Related]
8. Pseudomonas aeruginosa and mortality after hospital admission for chronic obstructive pulmonary disease.
Almagro P; Salvadó M; Garcia-Vidal C; Rodríguez-Carballeira M; Cuchi E; Torres J; Heredia JL
Respiration; 2012; 84(1):36-43. PubMed ID: 21996555
[TBL] [Abstract][Full Text] [Related]
9. Lower limb activity and its determinants in COPD.
Walker PP; Burnett A; Flavahan PW; Calverley PM
Thorax; 2008 Aug; 63(8):683-9. PubMed ID: 18487318
[TBL] [Abstract][Full Text] [Related]
10. Body composition by bioelectrical impedance predicts mortality in chronic obstructive pulmonary disease patients.
Slinde F; Grönberg A; Engström CP; Rossander-Hulthén L; Larsson S
Respir Med; 2005 Aug; 99(8):1004-9. PubMed ID: 15950141
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound measurement of rectus femoris cross-sectional area and the relationship with quadriceps strength in COPD.
Seymour JM; Ward K; Sidhu PS; Puthucheary Z; Steier J; Jolley CJ; Rafferty G; Polkey MI; Moxham J
Thorax; 2009 May; 64(5):418-23. PubMed ID: 19158125
[TBL] [Abstract][Full Text] [Related]
12. The importance of cardiovascular disease for mortality in patients with COPD: a prognostic cohort study.
Zhang J; Rutten FH; Cramer MJ; Lammers JW; Zuithoff NP; Hoes AW
Fam Pract; 2011 Oct; 28(5):474-81. PubMed ID: 21602286
[TBL] [Abstract][Full Text] [Related]
13. Post-exercise heart rate recovery and mortality in chronic obstructive pulmonary disease.
Lacasse M; Maltais F; Poirier P; Lacasse Y; Marquis K; Jobin J; LeBlanc P
Respir Med; 2005 Jul; 99(7):877-86. PubMed ID: 15939250
[TBL] [Abstract][Full Text] [Related]
14. The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort.
Casanova C; de Torres JP; Aguirre-Jaíme A; Pinto-Plata V; Marin JM; Cordoba E; Baz R; Cote C; Celli BR
Am J Respir Crit Care Med; 2011 Nov; 184(9):1015-21. PubMed ID: 21836135
[TBL] [Abstract][Full Text] [Related]
15. Preservation of lower limb strength after a short course of pulmonary rehabilitation with no maintenance: a 6-month follow-up study.
Houchen L; Deacon S; Sandland C; Collier R; Steiner M; Morgan M; Singh S
Physiotherapy; 2011 Sep; 97(3):264-6. PubMed ID: 21820546
[No Abstract] [Full Text] [Related]
16. Co-morbidities and hyperinflation are independent risk factors of all-cause mortality in very severe COPD.
Budweiser S; Harlacher M; Pfeifer M; Jörres RA
COPD; 2014 Aug; 11(4):388-400. PubMed ID: 24111878
[TBL] [Abstract][Full Text] [Related]
17. A better response in exercise capacity after pulmonary rehabilitation in more severe COPD patients.
Altenburg WA; de Greef MH; ten Hacken NH; Wempe JB
Respir Med; 2012 May; 106(5):694-700. PubMed ID: 22154126
[TBL] [Abstract][Full Text] [Related]
18. Sex differences in mortality in patients with COPD.
de Torres JP; Cote CG; López MV; Casanova C; Díaz O; Marin JM; Pinto-Plata V; de Oca MM; Nekach H; Dordelly LJ; Aguirre-Jaime A; Celli BR
Eur Respir J; 2009 Mar; 33(3):528-35. PubMed ID: 19047315
[TBL] [Abstract][Full Text] [Related]
19. Lung function decline and outcomes in an elderly population.
Mannino DM; Davis KJ
Thorax; 2006 Jun; 61(6):472-7. PubMed ID: 16517577
[TBL] [Abstract][Full Text] [Related]
20. Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes.
Garcia-Aymerich J; Gómez FP; Benet M; Farrero E; Basagaña X; Gayete À; Paré C; Freixa X; Ferrer J; Ferrer A; Roca J; Gáldiz JB; Sauleda J; Monsó E; Gea J; Barberà JA; Agustí À; Antó JM;
Thorax; 2011 May; 66(5):430-7. PubMed ID: 21177668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
